ENTRY       D09848            Mixture   Drug
NAME        Pioglitazone hydrochloride and glimepiride tablets (JP18);
            Pioglitazone and glimepiride;
            Duetact;
            Sonias (TN)
PRODUCT     DUETACT (Takeda Pharmaceuticals America)
  GENERIC   PIOGLITAZONE AND GLIMEPIRIDE (Prasco Laboratories)
            PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE (Sandoz)
COMPONENT   (Pioglitazone hydrochloride [DR:D00945] | Pioglitazone [DR:D08378]), Glimepiride [DR:D00593]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
REMARK      Therapeutic category: 3969
            ATC code: A10BD06
            Product: D09848<JP/US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Pioglitazone is primarily metabolized by CYP2C8.
            Glimepiride is primarily metabolized by CYP2C9.
METABOLISM  Enzyme: CYP2C8 [HSA:1558], CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD06 Glimepiride and pioglitazone
                  D09848  Pioglitazone hydrochloride and glimepiride tablets (JP18) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Pioglitazone Hydrochloride/ Glimepiride
                D09848  Pioglitazone hydrochloride and glimepiride tablets (JP18)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D09848  Pioglitazone hydrochloride and glimepiride tablets (JP18)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D09848  Pioglitazone hydrochloride and glimepiride tablets
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               D09848  Pioglitazone hydrochloride and glimepiride tablets
              DG01642  CYP2C9 substrate
               D09848  Pioglitazone hydrochloride and glimepiride tablets
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D09848  Pioglitazone hydrochloride and glimepiride tablets
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D09848  Pioglitazone hydrochloride and glimepiride tablets
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09848
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09848
DBLINKS     PubChem: 124490587
///
